Reading Disability
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
3 programsGraphoLearn reading interventionN/A1 trial
Reading TutoringN/A1 trial
preKN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Human BioSciencesGraphoLearn reading intervention
Human BioSciencesReading Tutoring
Human BioSciencespreK
Clinical Trials (3)
Total enrollment: 619 patients across 3 trials
Neurocognitive Factors in EdTech Intervention Response
Start: Nov 2020Est. completion: Aug 2026315 patients
N/ACompleted
Executive Function in Early Childhood
Start: Aug 2019Est. completion: Jul 2030260 patients
N/AEnrolling By Invitation
University of Washington Reading & Dyslexia Research Program
Start: May 2019Est. completion: Jun 202144 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.